BioMed Research International

BioMed Research International / 2020 / Article
Special Issue

The Role of Neuroinflammation in Cellular Damage in Neurodegenerative Diseases

View this Special Issue

Erratum | Open Access

Volume 2020 |Article ID 7254325 | https://doi.org/10.1155/2020/7254325

Aziza Alrafiah, Ebtisam Al-Ofi, Mona Talib Obaid, Nimah Alsomali, "Erratum to “Assessment of the Levels of Level of Biomarkers of Bone Matrix Glycoproteins and Inflammatory Cytokines from Saudi Parkinson Patients”", BioMed Research International, vol. 2020, Article ID 7254325, 1 page, 2020. https://doi.org/10.1155/2020/7254325

Erratum to “Assessment of the Levels of Level of Biomarkers of Bone Matrix Glycoproteins and Inflammatory Cytokines from Saudi Parkinson Patients”

Received13 Jul 2020
Accepted13 Jul 2020
Published30 Sep 2020

In the article titled “Assessment of the Levels of Level of Biomarkers of Bone Matrix Glycoproteins and Inflammatory Cytokines from Saudi Parkinson Patients” [1], multiple references were omitted in error. The references are shown below and listed as [2, 3].

These should supplement the following sentences in the article text:

Osteopontin (OPN) was revealed to be elaborate in inflammatory and degenerative mechanisms of the neurons [2]. OPN plays a critical role in PD due to its anti-inflammatory and antiapoptotic properties and its role in regulating iNOS transcription, reactive oxygen species production, and cytokines levels (9–10). In addition, it has been found that OPN sera and cerebrospinal fluid (CSF) amounts are greater in PD patients than controls, with CSF extent positively linked with concomitant dementia [3].

The error was introduced during the production process of the article, and Hindawi apologises for causing this error in the article.

References

  1. A. Alrafiah, E. Al-Ofi, M. T. Obaid, and N. Alsomali, “Assessment of the Levels of Level of Biomarkers of Bone Matrix Glycoproteins and Inflammatory Cytokines from Saudi Parkinson Patients,” BioMed Research International, vol. 2019, no. 6, Article ID 2690205, p. 6, 2019. View at: Publisher Site | Google Scholar
  2. M. Carecchio and C. Comi, “The role of osteopontin in neurodegenerative diseases,” Journal of Alzheimer's Disease, vol. 25, no. 2, pp. 179–185, 2011. View at: Publisher Site | Google Scholar
  3. W. Maetzler, D. Berg, N. Schalamberidze et al., “Osteopontin is elevated in Parkinson’s disease and its absence leads to reduced neurodegeneration in the MPTP model,” Neurobiology of Disease, vol. 25, no. 3, pp. 473–482, 2007. View at: Publisher Site | Google Scholar

Copyright © 2020 Aziza Alrafiah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views14
Downloads13
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.